Cigna news and information

Whether it's the lingering aftershock of the Great Recession, stepped-up efforts at cost control by providers or a combination of the two, slow-growing medical claims led to surging profits for big commercial health insurers in the second quarter.
FULL STORY »

With the use of genetic testing growing rapidly, Cigna Corp. has become the first major health insurer to require subscribers who are at risk for breast cancer, colorectal cancer syndromes or Long QT syndrome and are considering genetic testing to first meet with a certified genetic counselor.
FULL STORY »

Cigna Corp. will begin requiring patients who are at risk for breast cancer, colorectal cancer syndromes or Long QT syndrome and are considering genetic testing to first receive genetic counseling.
FULL STORY »

URAC, a Washington-based healthcare measurement and accreditation organization, has named Kylanne Green president and CEO, effective July 22. Green succeeds Alan Spielman, who left his post Feb. 15 after serving as president and CEO since 2005. Green, a nurse practitioner, previously...
FULL STORY »

Cigna Corp. has named its current VP of finance, Thomas McCarthy, to the role of executive VP and CFO. Effective July 12, McCarthy, 56, will replace Ralph Nicoletti, who recently announced his resignation.
FULL STORY »

Health insurance companies are expecting reduced Medicare Advantage payments to unfavorably impact revenue next year.
FULL STORY »

In an MGMA-ACMPE survey, medical practice professionals gave their highest overall payer-satisfaction ratings to Medicare Part B.
FULL STORY »

You'd think health insurance CEOs would be chilling the bubbly with Republican Mitt Romney's improved election prospects, but instead they're in a quandary.
FULL STORY »

Two major insurers separately announced new accountable care initiatives.
FULL STORY »

Seniors enrolled in seven of the 10 most popular Medicare prescription drug plans will be hit with double-digit premium hikes next year if they don't shop for a better deal, says a private firm that analyzes the highly competitive market.
FULL STORY »